Symptoms can include palpitations, dizziness, fainting, shortness of breath, anxiety, sweating, and chest discomfort or pain.

Different models on the development of Parkinson's disease might represent a disease largely triggered by something in our environment, hinting at ways of preventing a significant number of cases.

Immune Cells May Lead to More Parkinson's Cases in Men Feb. 25 ... related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression.

A subset of Parkinson’s disease is caused by CHCHD2, a gene which encodes a protein contained in the mitochondria of cells.

Parkinson’s can cause a condition called Parkinson’s disease dementia. This condition is marked by a decline in thinking, reasoning, and problem-solving. Parkinson’s disease is a progressive ...

Northwestern Medicine scientists have uncovered new insights into how neurofilaments act like Velcro in neurodegenerative ...

Slow the Spread. In the mouse brain, phospho-synuclein pathology (green) accumulates (top) in, from left to right, the motor ...

More information: Max A. Laansma et al, A worldwide study of subcortical shape as a marker for clinical staging in Parkinson's disease, npj Parkinson's Disease (2024). DOI: 10.1038/s41531-024-00825-9 ...

(MENAFN- EIN Presswire) Pathways Neuro Pharma shifts focus to rare pediatric diseases, advancing a groundbreaking non-agonist gene therapy for Juvenile Parkinson's Disease. Children diagnosed with ...

Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...